Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 1, 2000, Pages 114-118

  Vemulapalli, Ramesh ^a   Cravero, Silvio ^a,b   Calvert, Christine L ^a   Toth, Thomas E ^a   Sriranganathan, Nammalwar ^a   Boyle, Stephen M ^a   Rossetti, Osvaldo L ^b   Schurig, Gerhardt G ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN G2A; OUTER MEMBRANE PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; BRUCELLA ABORTUS; GENE DISRUPTION; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SHUTTLE VECTOR; STRAIN DIFFERENCE; VIRUS EXPRESSION;

EID: 0033976573     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.7.1.114-118.2000     Document Type: Article

References (31)

1. Acha, P., and B. Szyfres. 1980. Zoonoses and communicable diseases common to man and animals, p. 28-45. Pan American Health Organization, Washington, D.C.
2. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
3. Araya, L. N., and A. J. Winter. 1990. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect. Immun. 58:254-256.
4. Carroll, M. W., and B. Moss. 1995. E. coli β-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. BioTechniques 19:352-355.
5. Carus, W. S. 1998. Biological warfare threats in perspective. Crit. Rev. Microbiol. 24:149-155.
6. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
7. Coligan, J. E., A. M. Kruisbeek, D. H. Marulies, E. M. Shevach, and W. Strober (ed.). 1991. Current protocols in immunology, vol. 2, p. 8.4.1-8.10.6. John Wiley & Sons. Inc., New York, N.Y.
8. 7a. Committee on Care and Use of Laboratory Animals. 1985. Guide for the care and use of laboratory animals. National Institutes of Health publication no. 86-23. National Institutes of Health. Bethesda, Md.
9. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
10. Denoel, P. A., T. K. Vo, V. E. Weynants, A. Tibor, D. Gilson, M. S. Zygment, J. N. Limet, and J. J. Letesson. 1997. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J. Med. Microbiol. 46:801-806.
11. Guilloteau, L. A., K. Laroucau, N. Vizcaino, I. Jacques, and G. Dubray. 1999. Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice. Vaccine 17:353-361.
12. Jimenez de Bagues, M. P., P. H. Elzer, S. M. Jones, J. M. Blasco, F. M. Enright, G. G. Schurig, and A. J. Winter. 1994. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect. Immun. 62: 4990-4996.
13. Kaufmann, A. F., M. I. Meltzer, and G. P. Schmid. 1997. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis. 3:83-94.
14. Knudsen, K. A. 1985. Proteins transferred to nitrocellulose for use as immunogens. Anal. Biochem. 147:285-288.
15. Kovach, M. E., P. H. Elzer, G. T. Robertson, R. L. Chirhart-Gilleland, M. A. Christensen, K. M. Peterson, and R. M. Roop II. 1997. Cloning and nucleotide sequence analysis of a Brucella abortus gene encoding an 18 kDa immunoreactive protein. Microb. Pathog. 22:241-246.
16. Latimer, E., J. Simmers, N. Sriranganathan, R. M. Roop II, G. G. Schurig, and S. M. Boyle. 1992. Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice. Microb. Pathog. 12:105-113.
17. McQuiston, J. R., G. G. Schurig, N. Sriranganathan, and S. M. Boyle. 1995. Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol. Biol. 47:143-148.
18. McQuiston, J. R., R. Vemulapalli, T. J. Inzana, G. G. Schurig, N. Sriranganathan, D. Fritzinger, T. L. Hadfield, R. A. Warren, N. Snellings, D. Hoover, S. M. Hailing, and S. M. Boyle. 1999. Genetic characterization of a Tn5-disrupted glycosyltransterase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect. Immun. 67: 3830-3835.
19. Oliveira, S. C., and G. A. Splitter. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14:959-962.
20. Onate, A. A., R. Vemulapalli, E. Andrews, G. G. Schurig, S. Boyle, and H. Folch. 1999. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immun. 67:986-988.
21. Schurig, G. G., R. M. Roop, T. Bagchi, S. M. Boyle, D. Buhrman, and N. Sriranganathan. 1991. Biological properties of RB51: a stable rough strain of Brucella abortus. Vet. Microbiol. 28:171-188.
22. Splitter, G., S. Oliveira, M. Carey, C. Miller, J. Ko, and J. Covert. 1996. T lymphocyte mediated protection against facultative intracellular bacteria. Vet. Immunol. Immunopathol. 54:309-319.
23. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258.
24. Tabatabai, L. B., and G. W. Pugh, Jr. 1994. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptidc vaccine. Vaccine 12:919-924.
25. Tibor, A., I. Jacques, L. Guilloteau, J. M. Verger, M. Grayon, V. Wansard, and J. J. Letesson. 1998. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice. Infect. Immun. 66:5561-5564.
26. Tibor, A., E. Saman, P. de Wergifosse, A. Cloeckaert, J. N. Limet. and J. J. Letesson. 1996. Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two outer membrane proteins of Brucella abortus. Infect. Immun. 64:100-107.
27. Toth, T. E., J. A. Cobb, S. M. Boyle, R. M. Roop, and G. G. Schurig. 1995. Selective humoral immune response of Balb/C mice to Brucella abortus proteins expressed by vaccinia virus recombinants. Vet. Microbiol. 45:171-183.
28. Trujillo, I. Z., A. N. Zavala, J. G. Caceres, and C. Q. Miranda. 1994. Brucellosis. Infect. Dis. Clin. N. Am. 8:225-241.
29. Vemulapalli, R., A. J. Duncan, S. M. Boyle, N. Sriranganathan, T. E. Toth, and G. G. Schurig. 1998. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect. Immun. 66:5684-5691.
30. Zhan, Y., and C. Cheers. 1993. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.
31. Zhan, Y., J. Yang, and C. Cheers. 1993. Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect. Immun. 61:2841-2847.